Watson J F, Butler V P
J Clin Invest. 1972 Mar;51(3):638-48. doi: 10.1172/JCI106853.
Digoxin-specific antibodies are capable of removing essentially all intracellular digoxin from rat renal cortical slices or from human erythrocytes. In removing digoxin from erythrocytes, these antibodies are capable of reversing an effect of the drug on cellular potassium transport. This study provides direct evidence that antibodies are capable of removing, and thereby reversing the biological effect of, physiologically active low molecular weight substances after they have been taken up by mammalian cells. This biologic property of digoxin-specific antibodies suggests that autidigoxin sera may prove useful in the reversal of digoxin toxicity. Rapid and essentially quantitative removal of digoxin from red cells by antibody is not accompanied by an immediate restoration of patassium influx to normal levels. Identification of the mechanism of this phenomenon may provide useful information concerning the mode of action not only of digoxin, but also of the cation transport system of human erythrocytes.
地高辛特异性抗体能够从大鼠肾皮质切片或人红细胞中基本清除所有细胞内地高辛。在从红细胞中清除地高辛时,这些抗体能够逆转该药物对细胞钾转运的作用。本研究提供了直接证据,表明抗体能够在生理活性低分子量物质被哺乳动物细胞摄取后将其清除,从而逆转其生物学效应。地高辛特异性抗体的这种生物学特性表明,自身抗地高辛血清可能被证明对逆转地高辛毒性有用。抗体快速且基本定量地从红细胞中清除地高辛,并未伴随着钾流入立即恢复到正常水平。确定这一现象的机制不仅可能提供有关地高辛作用方式的有用信息,还可能提供有关人红细胞阳离子转运系统作用方式的有用信息。